Document Detail

Utilization patterns and net direct medical cost to Medicaid of irritable bowel syndrome.
MedLine Citation:
PMID:  14687449     Owner:  NLM     Status:  MEDLINE    
BACKGROUND: Patients with irritable bowel syndrome are frequent users of the health care system. DESIGN AND METHODS: This retrospective matched case-control study assessed the economic impact of irritable bowel syndrome on the Medicaid program by comparing the health care utilization and expenditures of Medicaid patients with irritable bowel syndrome in California and North Carolina with age-, sex-, and race-matched control groups without the syndrome. RESULTS: Average annual Medicaid expenditures per case of diagnosed irritable bowel syndrome were 2952 dollars and 5908 dollars in California and North Carolina, respectively; corresponding unadjusted net incremental expenditures were 962 dollars and 2191 dollars, respectively. In both states, patients with irritable bowel syndrome incurred greater costs than controls for physician visits, outpatient visits, and prescription drugs. CONCLUSIONS: Irritable bowel syndrome was shown to impose an economic burden on the Medicaid program. The cost of treating patients with irritable bowel syndrome is higher than the cost of treating matched ambulatory Medicaid recipients without the condition.
Bradley C Martin; Rahul Ganguly; Sandhya Pannicker; Feride Frech; Victoria Barghout
Related Documents :
11692059 - Impact of irritable bowel syndrome on personal relationships and working practices.
4004429 - Behçet's syndrome in a family with inflammatory bowel disease.
23238469 - Influence of drd2 and ankk1 polymorphisms on the manifestation of withdrawal syndrome s...
14504329 - Csf hypocretin levels in guillain-barré syndrome and other inflammatory neuropathies.
2599439 - Stress and oesophageal motility in normal subjects and patients with irritable bowel sy...
8964919 - A novel ganglioside, 9-o-acetyl gd1b, is recognized by serum antibodies in guillain-bar...
23171219 - Hermansky-pudlak syndrome: pigmentary and non-pigmentary defects and their pathogenesis.
15858309 - Non-syndrome multiple supplemental supernumerary teeth.
16001439 - Craniosynostosis: another feature of the 22q11.2 deletion syndrome.
Publication Detail:
Type:  Comparative Study; Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Current medical research and opinion     Volume:  19     ISSN:  0300-7995     ISO Abbreviation:  Curr Med Res Opin     Publication Date:  2003  
Date Detail:
Created Date:  2003-12-22     Completed Date:  2004-08-30     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  0351014     Medline TA:  Curr Med Res Opin     Country:  England    
Other Details:
Languages:  eng     Pagination:  771-80     Citation Subset:  IM    
University of Georgia College of Pharmacy, Pharmacy Care Administration Graduate Program, Athens, Georgia 30602, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Case-Control Studies
Cost of Illness*
Direct Service Costs*
Health Expenditures*
Irritable Bowel Syndrome / economics,  therapy*
Medicaid / utilization*
Middle Aged
North Carolina
Retrospective Studies

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Chronic venous insufficiency: the effects of health-care reforms on the cost of treatment and hospit...
Next Document:  Disintegration/dissolution profiles of copies of Fosamax (alendronate).